Ophthalmology Department, Rothschild Foundation Hospital, Paris, France.
Ophthalmology Department, Bichat Claude-Bernard Hospital, Paris, France ; and.
Cornea. 2024 Jul 1;43(7):890-894. doi: 10.1097/ICO.0000000000003477. Epub 2024 Jan 30.
The aim of this study was to assess the immediate and delayed effects of tear punctal occlusion with punctal plugs on tear meniscus height (TMH) in severe aqueous-deficient dry eye (ADDE) disease.
Consecutive patients with severe ADDE related to Sjögren syndrome or ocular graft-versus-host disease underwent inferior and superior occlusion with punctal plugs. TMH was measured using the LacryDiag ocular surface analyzer platform before, 10 minutes, and at least 1 month after punctal occlusion. The corneal fluorescein staining (CFS) score was graded with the Oxford scale (from 0 to 5). Ocular symptoms were graded with a visual analog scale (from 1 to 10).
We included 24 eyes of 24 patients (mean age 61 ± 9 years; mean follow-up 7 ± 5 months). The mean TMH was 0.19 ± 0.06 mm at baseline and increased significantly to 0.41 ± 0.13 mm ( P < 0.001) and 0.46 ± 0.17 mm ( P < 0.001) at 10 minutes after punctal plug insertion and at the end of follow-up, respectively. The median CFS score decreased from 3 ± 1 before plug insertion to 1 ± 2 at the end of follow-up ( P < 0.001). Many patients (67%; n = 16) reported subjective improvement of symptoms. TMH was negatively correlated with the CFS score and visual analog scale score assessing symptoms.
Upper and lower punctal occlusion increased TMH in patients with severe ADDE as soon as 10 minutes after plug insertion. TMH remained stable over time, which led to the relief of symptoms and reduced corneal staining.
本研究旨在评估严重水样液缺乏性干眼症(ADDE)患者泪点阻塞后即刻和延迟对泪膜半月板高度(TMH)的影响。
连续患有与干燥综合征或眼移植物抗宿主病相关的严重 ADDE 的患者接受下和上泪点阻塞,使用 LacryDiag 眼表面分析平台在阻塞前、10 分钟和至少 1 个月后测量 TMH。角膜荧光素染色(CFS)评分采用牛津量表(0-5 级)分级。眼部症状采用视觉模拟量表(1-10 级)分级。
我们纳入了 24 例 24 只眼(平均年龄 61±9 岁;平均随访 7±5 个月)。基线时平均 TMH 为 0.19±0.06mm,在泪点塞插入后 10 分钟和随访结束时分别显著增加至 0.41±0.13mm(P<0.001)和 0.46±0.17mm(P<0.001)。中位 CFS 评分从塞插入前的 3±1 降至随访结束时的 1±2(P<0.001)。许多患者(67%;n=16)报告症状有主观改善。TMH 与 CFS 评分和评估症状的视觉模拟量表评分呈负相关。
上和下泪点阻塞在塞插入后 10 分钟内即可增加严重 ADDE 患者的 TMH。TMH 随时间保持稳定,导致症状缓解和角膜染色减少。